Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Cancer & Oncology Companies

MolecularMD

Attachments

2012: $6 million Series B equity financing
2012: MolecularMD plans this year to submit a companion diagnostic test for regulatory approval that would work with Ariad Pharmaceutical's ponatinib drug.
Nextech Invest, which joins Ballast Point Ventures as an investor.
Portland, Oregon
The company is developing companion diagnostics for targeted cancer treatments, and will use the money to speed up the commercial launch of various new technologies and tests focused on next-generation sequencing and "rare mutant detection."